EVMN Evommune, Inc.

Fundamentals / CIK 0002044725 / USD

Evommune, Inc. reported $0 in revenue and a net loss of $113.1M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open EVMN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$20.09M$10.04M$0-$65.50MFY 2024 Revenue: $7.00MFY 2024 Net Income: -$66.81M2024FY 2025 Revenue: $13.00MFY 2025 Net Income: -$68.87M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Revenue $13.00M $7.00M
Research & Development $74.04M $64.24M
Total Operating Expenses $94.07M $77.01M
Operating Income -$81.07M -$70.01M
EBITDA -$80.47M -$69.51M
Interest Income $3.32M $3.24M
Income Before Tax -$68.87M -$68.31M
Income Tax Expense $0 $0
Net Income -$68.87M -$66.81M
Basic EPS -$11.22 -$45.29
Diluted EPS -$11.22 -$45.29
Basic Shares Outstanding 6.1M 1.5M
Diluted Shares Outstanding 6.1M 1.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Revenue $0 $0 $0 $0 $10.00M $0 $3.00M --
Research & Development $24.55M $26.41M $17.32M $20.40M $19.64M $19.64M $14.36M $13.29M
Total Operating Expenses $33.33M $34.90M $23.95M $29.72M $23.33M $22.99M $18.03M $16.52M
Operating Income -$33.33M -$34.90M -$23.95M -$29.72M -$13.33M -$22.99M -$15.03M -$16.52M
EBITDA -$33.13M -$34.70M -$23.85M -$29.62M -$13.23M -$22.79M -$14.83M --
Interest Income $2.48M $2.65M $2.28M $1.44M $862K $403K $613K $618K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$30.88M -$32.25M -$21.67M -$28.27M -$12.47M -$13.56M -$14.56M -$15.92M
Basic EPS -$0.85 -$0.89 -$0.64 -- -$8.07 -$8.80 -$9.48 -$89.18
Diluted EPS -$0.85 -$0.89 -$0.64 -- -$8.07 -$8.80 -$9.48 -$89.18
Basic Shares Outstanding 36.3M 36.1M 33.7M -- 1.5M 1.5M 1.5M 178.5K
Diluted Shares Outstanding 36.3M 36.1M 33.7M -- 1.5M 1.5M 1.5M 178.5K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $44.06M $16.25M
Short-Term Investments $105.1M $55.78M
Cash & Short-Term Investments $149.2M $72.04M
Total Current Assets $153.5M $73.99M
Property, Plant & Equipment, Net $994K $1.33M
Long-Term Investments $67.49M --
Other Non-Current Assets $101K $61K
Total Non-Current Assets $71.47M $2.07M
Total Assets $224.9M $76.06M
Accounts Payable $7.76M $8.26M
Deferred Revenue (Current) -- $3.00M
Other Current Liabilities $364K $573K
Total Current Liabilities $17.91M $27.98M
Other Non-Current Liabilities -- $535K
Total Non-Current Liabilities $1.47M $535K
Total Liabilities $19.38M $28.52M
Total Debt (incl. Leases) $2.06M $1.02M
Common Stock $3.0K $0
Retained Earnings -$221.1M -$152.2M
Total Stockholders' Equity $205.6M -$144.2M
Total Equity $205.6M -$144.2M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2024-12-31
Cash & Cash Equivalents $47.57M $60.03M $48.32M $44.06M $26.82M $16.25M
Short-Term Investments $121.1M $140.8M $163.1M $105.1M $49.24M $55.78M
Cash & Short-Term Investments $168.6M $200.8M $211.5M $149.2M $76.06M $72.04M
Total Current Assets $174.6M $204.2M $215.9M $153.5M $81.94M $73.99M
Property, Plant & Equipment, Net $1.63M $1.65M $1.64M $994K $970K $1.33M
Long-Term Investments $93.61M $87.21M $95.55M $67.49M -- --
Other Non-Current Assets $42K $66K $73K $101K $61K $61K
Total Non-Current Assets $103.7M $97.70M $106.6M $71.47M $2.60M $2.07M
Total Assets $278.3M $301.9M $322.5M $224.9M $84.54M $76.06M
Accounts Payable $9.10M $5.04M $4.04M $7.76M $3.58M $8.26M
Deferred Revenue (Current) -- -- -- -- -- $3.00M
Other Current Liabilities $469K $518K $571K $364K $371K $573K
Total Current Liabilities $20.48M $17.49M $10.60M $17.91M $10.42M $27.98M
Other Non-Current Liabilities -- -- -- -- $261K $535K
Total Non-Current Liabilities $6.45M $6.87M $7.30M $1.47M $261K $535K
Total Liabilities $26.93M $24.36M $17.90M $19.38M $10.68M $28.52M
Total Debt (incl. Leases) $8.19M $8.63M $9.11M $2.06M $765K $1.02M
Common Stock $4.0K $4.0K $4.0K $3.0K $0 $0
Retained Earnings -$305.9M -$275.0M -$242.8M -$221.1M -$192.8M -$152.2M
Total Stockholders' Equity $251.4M $277.6M $304.6M $205.6M -$183.1M -$144.2M
Total Equity $251.4M $277.6M $304.6M $205.6M -$183.1M -$144.2M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$68.87M -$66.81M
Depreciation & Amortization $600K $500K
Stock-Based Compensation $5.86M $1.72M
Change in Payables -$837K $6.51M
Operating Cash Flow -$76.44M -$58.20M
Capital Expenditure -$235K -$88K
Free Cash Flow -$76.68M -$58.28M
Purchases of Investments -$199.2M -$90.25M
Sales & Maturities of Investments $84.10M $86.35M
Investing Cash Flow -$115.3M -$3.99M
Financing Cash Flow $220.8M $49.42M
Net Change in Cash $29.02M -$12.77M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Net Income -$30.88M -$32.25M -$21.67M -$28.27M -$12.47M -$13.56M -$14.56M -$15.92M
Depreciation & Amortization $200K $200K $100K $100K $100K $200K $200K --
Stock-Based Compensation $4.42M $4.60M $3.45M $4.20M $560K $556K $544K $401K
Change in Payables $4.09M $983K -$3.75M $3.85M -$97K -$3.90M -$691K --
Operating Cash Flow -$25.88M -$20.32M -$27.50M -$16.70M -$9.63M -$26.21M -$23.90M --
Capital Expenditure -$233K -$183K -$83K -$104K -$131K $0 $0 --
Free Cash Flow -$26.11M -$20.50M -$27.59M -$16.80M -$9.77M -$26.21M -$23.90M --
Purchases of Investments -$47.53M -$17.64M -$108.8M -$160.4M -$38.77M $0 $0 --
Sales & Maturities of Investments $61.08M $49.12M $23.50M $37.60M $15.00M $18.00M $13.50M --
Investing Cash Flow $13.32M $31.29M -$85.36M -$122.9M -$23.91M $18.00M $13.50M --
Financing Cash Flow $94K $532K $117.1M $156.8M -$274K $64.34M -$152K --
Net Change in Cash -$12.46M $11.51M $4.25M $17.25M -$33.81M $56.13M -$10.55M --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Operating Margin -623.6% -1000.2%
Net Profit Margin -529.8% -954.4%
Return on Equity (ROE) -33.5% --
Return on Assets (ROA) -30.6% -87.8%
Current Ratio 8.57x 2.64x
Quick Ratio 8.33x 2.57x
Debt to Equity 0.01x --
Revenue Growth (YoY) +85.7% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Operating Margin -- -1018.9% -899.9% -623.6% -- -- -- --
Net Profit Margin -- -946.7% -759.9% -529.8% -- -- -- --
Return on Equity (ROE) -45.0% -34.1% -25.0% -33.5% -- -- -- --
Return on Assets (ROA) -40.6% -31.4% -23.6% -30.6% -- -- -- --
Current Ratio 8.52x 11.68x 20.36x 8.57x 7.87x -- -- --
Quick Ratio 8.23x 11.48x 19.94x 8.33x 7.30x -- -- --
Debt to Equity 0.03x 0.03x 0.03x 0.01x -- -- -- --
Revenue Growth (YoY) -100.0% -- -100.0% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002044725) · from September 30, 2024 Data through September 30, 2026 · synced Nov 20, 2026, 05:41 UTC · Open in terminal